Atlas Trials

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

Clinical trial NCT05885009 · RECRUITING

Trial details

NCT number
NCT05885009
Sponsor
SOLTI Breast Cancer Research Group
Status
RECRUITING
Study type
OBSERVATIONAL
Metastatic Prostate Cancer
Start date
2023-03-28
Primary completion
2026-03-28
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.